| William Crossley, PD | |
|
821 N Rock St, Sheridan, AR 72150-7623 | |
| (870) 942-5121 | |
| (870) 942-2592 |
| Full Name | William Crossley |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 821 N Rock St, Sheridan, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568671162 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PD05520 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| William Crossley, PD Po Box 217, Sheridan, AR 72150-0217 Ph: (870) 942-5121 | William Crossley, PD 821 N Rock St, Sheridan, AR 72150-7623 Ph: (870) 942-5121 |
News Archive
Strategies aimed at reducing childhood obesity should acknowledge individuals' rational taste preferences and apply insights from behavioral economics to design choice architecture that increases their likelihood of success, say two physician-scientists from the Perelman School of Medicine at the University of Pennsylvania and the Center for Health Incentives and Behavioral Economics in an editorial published in JAMA Pediatrics.
Italian Researchers say they have found what they believe to be the first direct link between high cholesterol levels and prostate cancer.
A study by researchers at Mayo Clinic's campus in Jacksonville, Florida has found that barriers to patients receiving stem cell therapy as part of their treatment for multiple myeloma include income, education, insurance status and access to care at an academic center or facility that treats a high volume of patients.
Kaiser Health News staff fact check some of the concerns swirling about in regard to the recently enacted health reform law.
Hospira, the world's leading provider of injectable drugs and infusion technologies, today announced the European Commission (EC) approval of Inflectra™ (infliximab), Europe's first biosimilar monoclonal antibody (mAb) therapy. Inflectra has been approved for the treatment of inflammatory conditions including rheumatoid arthritis (RA), ankylosing spondylitis, Crohn's disease (CD), ulcerative colitis (UC), psoriatic arthritis (PsA) and psoriasis.
› Verified 7 days ago
Mrs. Kelli Cunningham Gills, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 624 S Rock St, Sheridan, AR 72150 Phone: 870-942-5800 Fax: 870-942-5139 | |
Cynthia Hedden, P.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 821 N Rock St, Sheridan, AR 72150 Phone: 870-942-5121 Fax: 870-942-2592 | |
Donald Hedden, P.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 821 N Rock St, Sheridan, AR 72150 Phone: 870-942-5121 Fax: 870-942-2592 | |
Christen K Webb, P.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 821 N Rock St, Sheridan, AR 72150 Phone: 870-942-5121 Fax: 870-942-2592 | |
Casey Ward Hedden, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 821 N Rock St, Sheridan, AR 72150 Phone: 870-942-5121 Fax: 870-942-2592 | |
Mariya Yemets, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1308 S Rock St, Sheridan, AR 72150 Phone: 870-942-5045 |